Dr. William C Chapman MD
Surgical Oncologist | Surgical Oncology4921 Parkview Pl Suite 8c Saint Louis MO, 63110
Dr. William Chapman is a surgical oncologist practicing in Saint Louis, MO. Dr. Chapman specializes in diagnosing, staging and treating cancer-related symptoms. Surgical oncologists also decide if the patient is a candidate for surgery or other cancer treatments based on certain factors such as age, physical fitness and other possible coexisting medical conditions
Education and Training
Med Univ of Sc Coll of Med, Charleston Sc 1984
Medical University of South Carolina College of Medicine 1984
SurgeryAmerican Board of SurgeryABS
- Antiperistaltic Roux-en-Y biliary-enteric bypass after bile duct injury: a technical error in reconstruction.
- Image-guided surgery: preliminary feasibility studies of frameless stereotactic liver surgery.
- Acute pancreatitis after cardiac transplantation and other cardiac procedures: case-control analysis in 24,631 patients.
- Acute lung injury after hepatic cryoablation: correlation with NF-kappa B activation and cytokine production.
- Embryology, anatomy, and surgical applications of the extrahepatic biliary system.
- Surface registration for use in interactive, image-guided liver surgery.
- The incidence of splenectomy is decreasing: lessons learned from trauma experience.
- Technical advances toward interactive image-guided laparoscopic surgery.
- Effective control of hepatic bleeding with a novel collagen-based composite combined with autologous plasma: results of a randomized controlled trial.
- Hepatic cryoablation-induced acute lung injury: histopathologic findings.
- Registration of physical space to laparoscopic image space for use in minimally invasive hepatic surgery.
- Ischemic optic neuropathy after liver transplantation.
- Bile duct injury following laparoscopic cholecystectomy: a cause for continued concern.
- Chemoembolization and interstitial therapies for hepatocellular carcinoma.
- Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study.
- Effects of hepatitis C virus infection and its recurrence after liver transplantation on functional performance and health-related quality of life.
- Hepatic cryoablation-induced multisystem injury: bioluminescent detection of NF-kappaB activation in a transgenic mouse model.
- Biliary reconstruction is enhanced with a collagen-polyethylene glycol sealant.
- Modulation of endotoxin-induced NF-kappa B activation in lung and liver through TNF type 1 and IL-1 receptors.
- Water warming garment versus forced air warming system in prevention of intraoperative hypothermia during liver transplantation: a randomized controlled trial [ISRCTN32154832].
- Lack of optimal T-cell reactivity against the hepatitis C virus is associated with the development of fibrosis/cirrhosis during chronic hepatitis.
- The role of [18F]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma.
- Concomitant augmentation of type 1 CD4+ and CD8+ T-cell responses during successful interferon-alpha and ribavirin treatment for chronic hepatitis C virus infection.
- Indications and limitations of liver transplantation for hepatocellular carcinoma.
- Multi-organ inflammation after hepatic cryoablation in BALB/c mice.
- Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma.
- Natural antibodies prevent in vivo transmission of porcine islet-derived endogenous retrovirus to human cells.
- Human immune responses to porcine endogenous retrovirus-derived peptides presented naturally in the context of porcine and human major histocompatibility complex class I molecules: implications in xenotransplantation of porcine organs.
- Laparoscopic cholecystectomy.
- Registration of medical images using an interpolated closest point transform: method and validation.
- Liver transplantation in a patient with undiagnosed bipolar disorder.
- Orthotopic liver transplant and hepatic resection: Lessons learned from complimentary disciplines.
- Liver transplantation for hepatocellular carcinoma: expanding special priority to include stage III disease.
- Interleukin-1beta is prominent in the early pulmonary inflammatory response after hepatic injury.
- Compensating for intraoperative soft-tissue deformations using incomplete surface data and finite elements.
- Complement depletion enhances pulmonary inflammatory response after liver injury.
- Improved islet yields from pancreas preserved in perflurocarbon is via inhibition of apoptosis mediated by mitochondrial pathway.
- Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival.
- Concepts and preliminary data toward the realization of image-guided liver surgery.
- Interleukin-1beta is the primary initiator of pulmonary inflammation following liver injury in mice.
- Primary sclerosing cholangitis: role of liver transplantation.
- Radiofrequency ablation of recurrent hepatocellular carcinoma in a patient after liver transplantation: two-year follow-up.
- Role of intra-islet endothelial cells in islet allo-immunity.
- Elevated soluble CD30 characterizes patients with hepatitis C virus-induced liver allograft cirrhosis.
- Liver paper summary: IHPBA meeting 2004, Washington, DC.
- MRI characterization of 124 CT-indeterminate focal hepatic lesions: evaluation of clinical utility.
- Are new treatment methods of gallbladder stones the death-knell for gallstone surgery?
- Liver transplant for hepatitis C virus: effect of using older donor grafts on short- and medium-term survival.
- Positron emission tomography enhancing tumor thrombus in patient with renal cell carcinoma.
- Topical use of recombinant human thrombin for operative hemostasis.
- Advanced donor age alone does not affect patient or graft survival after liver transplantation.
- The role of liver transplantation for hepatic adenomatosis in the pediatric population: case report and review of the literature.
- No silver bullet in liver transection: what has 35 years of new technology added to liver surgery?
- Ischemic colitis. An ever-changing spectrum?
- Fluorescent in situ hybridization testing in primary sclerosing cholangitis: useful testing or a random chance result?
- Radiofrequency ablation for resectable colorectal hepatic metastases: is it time for a randomized controlled trial?
- Surgical treatment of hepatocellular carcinoma: expert consensus statement.
- Topical recombinant human thrombin in surgical hemostasis.
- Short- and long-term outcomes after steatotic liver transplantation.
- Endoplasmic reticulum stress is a mediator of posttransplant injury in severely steatotic liver allografts.
- Tumor size remains key for prediction of hepatocellular carcinoma recurrence after liver transplantation.
- Towards more effective liver allocation criteria for hepatocellular carcinoma: tumor response to locoregional therapy.
- Conventional Surgical Treatment of Hepatocellular Carcinoma.
- Hepatocellular carcinoma: a review of the surgical approaches to management.
- Novel three-dimensional imaging technique improves the accuracy of hepatic volumetric assessment.
- Donor graft steatosis influences immunity to hepatitis C virus and allograft outcome after liver transplantation.
- Ischemia-reperfusion injury in rat steatotic liver is dependent on NFκB P65 activation.
- ABO-incompatible organ transplantation.
- Liver transplantation for hepatocellular carcinoma: long-term results suggest excellent outcomes.
- Novel in vitro model for studying hepatic ischemia-reperfusion injury using liver cubes.
- Hepatic hemangiopericytoma/solitary fibrous tumor: a review of our current understanding and case study.
- Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial.
- Transplantation for hepatocellular carcinoma: the North American experience.
- Teach your children well: stage IV colorectal cancer and variability in practice
- The role of molecular chaperonins in warm ischemia and reperfusion injury in the
- Using ALPPS to induce rapid liver hypertrophy in a patient with hepatic fibrosis and portal vein thrombosis.
- Hepatitis C virus mediated changes in miRNA-449a modulates inflammatory biomarker YKL40 through components of the NOTCH signaling pathway.
- Once weekly fluconazole for antifungal prophylaxis post-liver transplantation.
- Liver transplantation for unresectable metastases to the liver: a new era in transplantation or a time for caution?
- Outcomes with split liver transplantation are equivalent to those with whole organ transplantation.
- Renal function at two years in liver transplant patients receiving everolimus:
- Perioperative blood transfusion affects hepatitis C virus (HCV)-specific immune responses and outcome following liver transplantation in HCV-infected patients.
- Interplay between immune responses to HLA and non-HLA self-antigens in allograft rejection.
- Combined hepatocellular and cholangiocarcinoma (biphenotypic) tumors: imaging features and diagnostic accuracy of contrast-enhanced CT and MRI.
- Hepatocellular carcinoma: resection versus transplantation.
- Hepatitis C virus induced miR200c down modulates FAP-1, a negative regulator of Src signaling and promotes hepatic fibrosis.
- Bouveret's syndrome complicated by classic gallstone ileus: progression of disease or iatrogenic?
- Protective role of bortezomib in steatotic liver ischemia/reperfusion injury through abrogation of MMP activation and YKL-40 expression.
- Immune responses to collagen-IV and fibronectin in renal transplant recipients with transplant glomerulopathy.
- Hepatitis C virus-induced changes in microRNA 107 (miRNA-107) and miRNA-449a modulate CCL2 by targeting the interleukin-6 receptor complex in hepatitis.
- A novel organ donor facility: a decade of experience with liver donors.
- Hepatic venous outflow obstruction in pediatric liver transplantation: technical considerations in prevention, diagnosis, and management.
- CD47 blockade reduces ischemia-reperfusion injury and improves outcomes in a rat kidney transplant model.
- Liver transplantation for metastatic neuroendocrine tumors.
- Morbid obesity in liver transplant recipients adversely affects longterm graft
- Current surgical treatment strategies for hepatocellular carcinoma in North America.
- Comparison of the transcriptional landscapes between human and mouse tissues.
- CD47 blockade reduces ischemia/reperfusion injury and improves survival in a rat liver transplantation model.
- BH3-only proteins contribute to steatotic liver ischemia-reperfusion injury.
- Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma.
- High-risk liver transplant candidates: An ethical proposal on where to draw the line.
- Outcomes Using Grafts from Donors after Cardiac Death.
- Organ Procurement Organization Liver Acquisition Costs Could More Than Double
- Biphenotypic Primary Liver Carcinomas: Assessing Outcomes of Hepatic Directed Therapy.
- Normothermic extracorporeal liver perfusion for donation after cardiac death (DCD) livers.
- Liver Transplantation and Donor Age: In Reply to Detry.
- Fibrin Sealant Patch (TachoSil) vs Oxidized Regenerated Cellulose Patch (Surgicel Original) for the Secondary Treatment of Local Bleeding in Patients Undergoing Hepatic Resection: A Randomized Controlled Trial.
- The new lottery ticket: Share 35.
- Organ Donor Recovery Performed at an Organ Procurement Organization-Based Facility Is an Effective Way to Minimize Organ Recovery Costs and Increase Organ Yield.
- Surgical Training in the United States: Is It Time for a Paradigm Shift?
- Colorectal liver metastases: disappearing lesions in the era of Eovist hepatobiliary magnetic resonance imaging.
- Results of Simultaneous Liver and Kidney Transplantation: A Single-Center Review.
- HPB Surgery: The Specialty is Here to Stay, but the Training is in Evolution.
- Attenuation of Ischemia-Reperfusion Injury and Improvement of Survival in Recipients of Steatotic Rat Livers Using CD47 Monoclonal Antibody.
- Epidemiology of Bloodstream Infections in a Multicenter Retrospective Cohort of Liver Transplant Recipients.
- Physician-Patient Communication is Associated With Hepatocellular Carcinoma Screening in Chronic Liver Disease Patients.
- Liver transplantation for hepatocellular carcinoma: current update on treatment and allocation.
- Liver Transplantation for Advanced Hepatocellular Carcinoma after Downstaging Without Up-Front Stage Restrictions.
- Liver Transplantation for Malignant Primary Pediatric Hepatic Tumors.
- Neoadjuvant Locoregional Therapy and Recurrent Hepatocellular Carcinoma after Liver Transplantation.
- LI-RADS and transplantation for hepatocellular carcinoma.
- Development of immune response to tissue-restricted self-antigens in simultaneous kidney-pancreas transplant recipients with acute rejection.
- CD47 blockade reduces ischemia/reperfusion injury in donation after cardiac death rat kidney transplantation.
- Surgeon Variation in Intraoperative Supply Cost for Pancreaticoduodenectomy: Is Intraoperative Supply Cost Associated with Outcomes?
- Anti-CD47 Monoclonal Antibody Therapy Reduces Ischemia-Reperfusion Injury of Renal Allografts in a Porcine Model of Donation after Cardiac Death.
- Diagnosis and management of blunt pancreatic injury.
- Compression fracture as a complication of pseudarthrosis in a scoliosis fusion.
- Transfer of the brachioradialis for hands deformed by cerebral palsy.
- Dysphagia lusoria: aberrant right subclavian artery with a Kommerell's diverticulum.
- Surgical clips: a cause of late recurrent gallstones.
- Hepatocellular carcinoma outcomes based on indicated treatment strategy.
- Liver Cancer
- Pancreatic Cancer
- Bile Duct Cancer
- Lightpod Neo
- Vanderbilt Univ Med Ctr, General Surgery
- Vanderbilt University Medical Center Program
Dr. William C Chapman MD's Practice location
Saint Louis, MO 63110Get Direction
Dr. William C Chapman MD's reviewsWrite Review
Patient Experience with Dr. Chapman
- Alternative Treatments for Bladder Cancer
Alternative Treatments for Bladder CancerCancer occurs in various stages, and as it moves from one stage to another, it gets worse. Therefore, as the condition progresses, more effective methods of treatment have to be applied. At times, even two treatment methods can be applied together.In...
- What Tests Determine Pancreatic Cancer?
Pancreatic cancer is a cancer that begins in the pancreas, which is the organ that lies behind the lower part of the stomach. This type of cancer is really difficult to diagnose and it is often detected late. In most cases, by the time this cancer is detected, it has already spread rapidly and thus...
- How Can Skin Grafting Treat Melanoma?
What is melanoma?Melanoma is a type of skin cancer that affects the melanocytes or the skin cells that contain the pigment melanin. It is caused when long or repeated exposure to UV radiation damages the DNA of these skin cells and causes them to divide uncontrollably forming a malignant tumor....
- Treatment Options for Cervical Cancer
Cervical cancer is one of the most common types of cancer in women. However, unlike the other forms of cancer, cervical cancer can be cured if it is discovered early on. That’s why cervical screening tests are necessary.Cervical cancer usually has no apparent symptoms in the primary stages. The...
- Bone Health Drugs for Breast Cancer
IntroductionLike any other drug or therapy, breast cancer treatment also has its own side effects. One of the side effects of breast cancer treatment is rapid bone loss leading to osteoporosis. The following are treatments for breast cancer that can significantly cause bone loss:...
- What Is Gastric Cancer: Causes, Symptoms, Diagnosis, and Treatment
Gastric cancer, also known as stomach cancer, begins when cancer cells form in the inner lining of the stomach. This disease does not show clear signs and symptoms until it enters the later stages. The cancer may spread from the stomach to essential parts like the liver, lungs, bones, and lymph...
- Dr. Jovita Un Oruwari MD15945 Clayton Rd Ballwin MO 63011
- Dr. Pamela Wilbanks Bunting DO4921 Parkview Pl Saint Louis MO 63110
- Dr. Sarah E Snell MD12700 Southfork Rd Saint Louis MO 63128
- Dr. Diane M Radford MD15945 Clayton Rd Ballwin MO 63011
- Dr. Marlys E Schuh MD15945 Clayton Rd Ballwin MO 63011
- Dr. Maria Bernadette Doyle MD4921 Parkview Pl Saint Louis MO 63110